Resource centre

Main menu

190 results

Direct analysis

Getting started guide
Getting started guide: biopharma
October 15 2025
Application note
Application note: Comprehensive genomic and epigenomic profiling with the Oxford Nanopore Hereditary Cancer Panel
September 16 2025
Brochure
Flyer: Hereditary Cancer Panel
September 3 2025
Brochure
Introductory guide: unlocking the biopharma development pipeline with Oxford Nanopore
April 16 2025
Publication
A systematic benchmark of nanopore long-read RNA sequencing for transcript-level analysis in human cell lines
March 13 2025
Brochure
Brochure: multiomic sequencing
February 24 2025
Publication
An optimised protocol for quality control of gene therapy vectors using nanopore direct RNA sequencing
October 28 2024
Publication
Direct RNA sequencing of astronaut blood reveals spaceflight-associated m6A increases and haematopoietic transcriptional responses
June 11 2024
Video
London Calling 2024 technology update
May 24 2024
Video
Innovations in mRNA vaccine precision manufacturing
May 24 2024
Video
Full-length transcript atlas of the developing human cortex
May 24 2024
Video
NCM Houston: Native RNA sequencing with RNA0004
December 6 2023
Publication
Long-read RNA sequencing redefines the clear cell renal cell carcinoma transcriptome and reveals novel genes and transcripts associated with disease recurrence and immune evasion
September 8 2023
Publication
Borg extrachromosomal elements of methane-oxidizing archaea have conserved and expressed genetic repertoires
August 1 2023
Video
London Calling 2023: Real-time genomics for One Health
May 19 2023
Poster
Exploring the potential of chemo-enzymatic technology for improved detection of epigenetic modifications with nanopore sequencing
May 19 2023
Poster
Direct RNA sequencing of dsRNA using Oxford Nanopore Technologies
May 19 2023
Publication
Quantitative analysis of tRNA abundance and modifications by nanopore RNA sequencing
April 6 2023
Publication
Nanopore sequencing unveils the complexity of the cold-activated murine brown adipose tissue transcriptome
December 14 2022
Poster
Benchmarking nanopore methylation analysis by comparison to publicly available bisulphite datasets
December 5 2022

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Accessibility

About Oxford Nanopore

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.

ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.

Select Language

Focus areas

Resource Centre

Getting started guide: biopharma

Application note: Comprehensive genomic and epigenomic profiling with the Oxford Nanopore Hereditary Cancer Panel

Flyer: Hereditary Cancer Panel

Introductory guide: unlocking the biopharma development pipeline with Oxford Nanopore

A systematic benchmark of nanopore long-read RNA sequencing for transcript-level analysis in human cell lines

Brochure: multiomic sequencing

An optimised protocol for quality control of gene therapy vectors using nanopore direct RNA sequencing

Direct RNA sequencing of astronaut blood reveals spaceflight-associated m6A increases and haematopoietic transcriptional responses

London Calling 2024 technology update

Innovations in mRNA vaccine precision manufacturing

Full-length transcript atlas of the developing human cortex

NCM Houston: Native RNA sequencing with RNA0004

Long-read RNA sequencing redefines the clear cell renal cell carcinoma transcriptome and reveals novel genes and transcripts associated with disease recurrence and immune evasion

Borg extrachromosomal elements of methane-oxidizing archaea have conserved and expressed genetic repertoires

London Calling 2023: Real-time genomics for One Health

Exploring the potential of chemo-enzymatic technology for improved detection of epigenetic modifications with nanopore sequencing

Direct RNA sequencing of dsRNA using Oxford Nanopore Technologies

Quantitative analysis of tRNA abundance and modifications by nanopore RNA sequencing

Nanopore sequencing unveils the complexity of the cold-activated murine brown adipose tissue transcriptome

Benchmarking nanopore methylation analysis by comparison to publicly available bisulphite datasets

shared.filter

Products

Research areas

Techniques